15. Subsequent Events (Notes)

3 Months Ended

Mar. 31, 2020

Subsequent Events [Abstract]

Subsequent Events [Text Block]

Subsequent Events

Acquisition

In April 2020, we acquired all the issued and outstanding stock of Celsee, Inc. for approximately $100 million and contingent consideration related to the achievement of sales milestones that could potentially range from $0 to $60 million. We believe this acquisition will complement our offerings in the Life Science products as Celsee, Inc. offers instruments and consumables for the isolation, detection, and analysis of single cells. The acquisition will be included in our Life Science segment's results of operations from the acquisition date and will be accounted for as a business acquisition. We have not yet allocated the purchase price to the acquired assets and liabilities.

Sale of a Division

In April 2020, we received $12.2 million for the sale of our Informatics division, which focused on providing and developing comprehensive, high-quality spectral databases and associated software. The product line was part of our Other Operations segment.